Consistent with the enhancement of expression of IFN-γ, subcutaneously administered PLP significantly increased the infiltration of CD4+ IFN-γ+ and CD8+ IFN-γ+ T cells to the tumor sites (Figure 5G). This evidence concerns the gene CD8A and neoplasm.